Profiling persistent tubercule bacilli from patient sputa during therapy predicts early drug efficacy. (2016)

First Author: Honeyborne I

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1186/s12916-016-0609-3

PubMed Identifier: 27055815

Publication URI: http://europepmc.org/abstract/MED/27055815

Type: Journal Article/Review

Volume: 14

Parent Publication: BMC medicine

ISSN: 1741-7015